SEC Company Response from Annovis Bio, Inc. (ANVS) (CIK 0001477845) (ANVS) — Jan 24, 2020
Annovis Bio, Inc. (ANVS) (CIK 0001477845)
Date: Jan. 24, 2020 · CIK: 0001477845 · Accession: 0001104659-20-006739
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232529
Letter
Re: Annovis Bio, Inc.
January 24, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1,
File No. 333-232529
Acceleration Request
Requested Date: January 28, 2019
Requested Time: 4:30 p.m. Eastern Time (US)
Ladies and Gentlemen:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representative of the several underwriters, hereby join in the request of Annovis Bio, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time (US), on January 28, 2020, or at such later time as the Company or its outside counsel, Venable LLP, may request via a telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Pursuant to Rule 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the preliminary prospectus to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
THINKEQUITY
Show Raw Text
CORRESP 1 filename1.htm January 24, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Annovis Bio, Inc. Registration Statement on Form S-1, File No. 333-232529 Acceleration Request Requested Date: January 28, 2019 Requested Time: 4:30 p.m. Eastern Time (US) Ladies and Gentlemen: In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representative of the several underwriters, hereby join in the request of Annovis Bio, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time (US), on January 28, 2020, or at such later time as the Company or its outside counsel, Venable LLP, may request via a telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Pursuant to Rule 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the preliminary prospectus to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, THINKEQUITY a division of Fordham Financial Management, Inc. By: /s/ Eric Lord Name: Eric Lord Title: Head of Investment Banking